Oesophagus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

A CR-UK Phase I Trial of LY3143921
Conditions:   a. Colorectal Cancer;   b. High Grade Serous Ovarian Cancer;   c. Non Small-cell Lung Cancer (Squamous Cell Variant);   d. Squamous Carcinoma of the Oesophagus;   e. Squamous Carcinoma of the Head and Neck (HPV Negative);   f. Urothelial Cancer;   g. Breast Cancer (Triple  Negative Type);   h. Pancreatic Cancer Intervention:   Drug: LY3143921 hydrate Sponsor:   Cancer Research UK Not yet recruiting - verified March 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2017 Category: Research Source Type: clinical trials